Trial Profile
An Open Label, Exploratory Study on the Effect of rhBSSL on the Fat Absorption in Patients With Cystic Fibrosis and Pancreatic Insufficiency
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bucelipase alfa (Primary)
- Indications Cystic fibrosis; Pancreatic disorders
- Focus Therapeutic Use
- 03 Jun 2014 New trial record